Showing results (321-330 of 343) with videos related to
Sort By:
Pageof 35
British Journal of Pharmacology|March 25, 2009
Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3))M Jongsma, J van Unen, P B van Loenen, et al.Deutsche Medizinische Wochenschrift (1946)|February 6, 2014
[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology]V Schwenger, B A Remppis, R Westenfeld, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1990
Effects of insulin-induced hypoglycemia on beta 2-adrenoceptor density and proliferative responses of human lymphocytesL J van Tits, A Daul, H J Bauch, et al.The American Journal of Physiology|January 1, 1990
Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent processL J Van Tits, M C Michel, H Grosse-Wilde, et al.Tijdschrift Voor Psychiatrie|September 24, 2010
[Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines]H G Ruhé, J Booij, H C van Weert, et al.Immunopharmacology|September 1, 1991
Does verapamil act as an immunomodulatory drug in vivo?A S Maisel, D Murray, S Polizzi, et al.Molecular Pharmacology|October 1, 1992
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacyM C Michel, W Gaida, A G Beck-Sickinger, et al.Circulation|March 1, 1990
Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterolO E Brodde, A Daul, M Michel-Reher, et al.Hypertension (Dallas, Tex. : 1979)|April 1, 1992
On the role of renal alpha-adrenergic receptors in spontaneously hypertensive ratsM C Michel, S Jäger, R Casto, et al.The Journal of Clinical Investigation|February 1, 1990
Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatmentA S Maisel, K U Knowlton, P Fowler, et al.Pageof 35